Saturday 17 October 2026
Export INFU’s income statement to Excel — free account
InfuSystems Holdings, Inc.
INFU Healthcare Medical Devices
InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024. In the quarter to June 2026, revenue grew 2.59%, EPS grew 33.3%, free cash flow fell 66.5% and total debt fell 22.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
13.33
0.59
−4.24%
Follow INFU
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 121.86 | 21.59 | 243.29 | 0.00 | 267.45 | 84.50 | 28.03 |
Piotroski F-Score |
4 | 4 | 5 | 7 | 7 | 4 | 5 | 7 | 7 | 8 |
P/S ratio |
0.79 | 0.75 | 1.10 | 2.07 | 3.88 | 3.41 | 1.63 | 1.70 | 1.33 | 1.29 |
Altman Z-Score |
0.98 | 0.51 | 0.76 | 1.82 | 4.78 | 4.74 | 2.54 | 3.36 | 3.25 | 3.74 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.70 |
Altman Z″-Score (non-manufacturers) |
0.14 | (1.94) | (2.37) | (2.02) | 0.35 | 0.04 | (0.17) | 0.45 | 0.87 | 1.27 |
Beneish M-Score |
(2.92) | (4.51) | (3.58) | (2.94) | (2.42) | (3.14) | (3.21) | (2.72) | (3.24) | (3.30) |
P/Operating CF |
13.28 | 14.78 | 23.16 | 38.77 | 49.61 | 94.17 | 39.34 | 45.99 | 22.66 | 26.00 |
P/B ratio |
1.09 | 1.73 | 3.60 | 7.54 | 9.27 | 7.24 | 3.74 | 4.10 | 3.12 | 3.23 |
Price to Tangible BV |
2.85 | 8.30 | 127.91 | 24.50 | 12.77 | 10.39 | 5.01 | 5.21 | 3.80 | 3.96 |
EV/Sales |
1.23 | 1.10 | 1.54 | 2.52 | 4.18 | 3.73 | 1.94 | 1.93 | 1.51 | 1.41 |
EV/EBITDA |
88.79 | 0.00 | 248.45 | 20.49 | 17.79 | 21.73 | 14.10 | 14.55 | 10.44 | 7.98 |
EV/Operating CF |
10.93 | 10.16 | 9.05 | 14.71 | 20.06 | 20.88 | 12.15 | 21.68 | 9.93 | 8.27 |
EV/FCF |
(11.41) | (18.82) | (15.65) | (10.87) | (83.42) | (47.69) | (30.60) | (28.60) | (35.20) | 33.45 |
Quick Ratio |
0.91 | 1.18 | 0.94 | 0.67 | 1.06 | 1.21 | 1.18 | 1.28 | 1.23 | 1.29 |
Current Ratio |
1.26 | 1.42 | 1.19 | 0.88 | 1.29 | 1.71 | 1.71 | 1.95 | 1.82 | 1.80 |
Net Debt/EBITDA |
2.64 | 2.86 | 2.50 | 2.25 | 1.27 | 1.87 | 2.19 | 1.73 | 1.20 | 0.65 |
Debt/Assets |
35.77% | 41.27% | 52.67% | 48.44% | 40.00% | 33.92% | 33.36% | 28.28% | 23.03% | 19.52% |
Debt/Equity |
0.68 | 0.92 | 1.65 | 1.72 | 0.95 | 0.69 | 0.69 | 0.56 | 0.41 | 0.34 |
Asset Turnover |
0.74 | 0.86 | 1.01 | 1.13 | 1.11 | 1.05 | 1.12 | 1.24 | 1.31 | 1.41 |
Operating CF/Net income |
(35.63) | (0.37) | (10.40) | 10.19 | 1.17 | 12.90 | 973.17 | 12.87 | 8.72 | 3.68 |
Capex/Depreciation |
(0.46) | 0.07 | (0.44) | (1.59) | (0.87) | (0.90) | (0.85) | (0.53) | (1.05) | (0.40) |
Interest Coverage |
0.72 | (2.86) | 0.29 | 1.85 | 7.03 | 2.05 | 1.18 | 1.88 | 3.88 | 9.18 |
| (0.44%) | (50.73%) | (4.26%) | 6.36% | 54.95% | 3.19% | 0.04% | 1.74% | 4.27% | 11.54% | |
| (0.23%) | (25.07%) | (1.65%) | 1.90% | 19.67% | 1.46% | 0.02% | 0.86% | 2.27% | 6.49% | |
ROIC |
0.74% | (4.26%) | 0.52% | 3.79% | 7.89% | 2.17% | 1.28% | 3.15% | 5.33% | 10.10% |
Return on Tangible Assets |
(3.51%) | (303.35%) | (26.12%) | 91.04% | 156.57% | 10.37% | 0.12% | 4.54% | 12.65% | 33.96% |
Average Days of Receivables |
59.96 | 57.95 | 52.15 | 54.43 | 55.17 | 54.92 | 56.02 | 57.54 | 57.26 | 58.28 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
62.08% | 66.37% | 58.32% | 53.45% | 51.27% | 54.42% | 53.59% | 46.92% | 47.09% | 47.67% |
Intangible Assets out of Total Assets |
0.32 | 0.36 | 0.31 | 0.20 | 0.12 | 0.15 | 0.12 | 0.11 | 0.10 | 0.11 |
Share Based Compensation of Revenue |
0.66% | 0.96% | 1.43% | 1.23% | 2.68% | 6.26% | 3.48% | 3.24% | 3.31% | 3.04% |
Graham Net Nets |
(0.45) | (0.38) | (0.35) | (0.22) | (0.07) | (0.08) | (0.15) | (0.09) | (0.08) | (0.04) |
Graham Number |
0.00 | 0.00 | 0.00 | 1.34 | 6.30 | 1.92 | 0.00 | 1.46 | 2.47 | 4.47 |
Earnings Yield |
(0.36%) | (38.97%) | (1.45%) | 0.82% | 4.63% | 0.41% | (0.03%) | 0.37% | 1.18% | 3.57% |
Free Cash Flow Yield |
(13.68%) | (7.80%) | (8.94%) | (11.15%) | (1.29%) | (2.29%) | (3.87%) | (3.97%) | (3.21%) | 3.26% |
Revenue per Share |
3.12 | 3.13 | 3.13 | 4.11 | 4.84 | 4.99 | 5.32 | 5.98 | 6.34 | 6.94 |
Operating CF per Share |
0.35 | 0.34 | 0.53 | 0.70 | 1.01 | 0.89 | 0.85 | 0.53 | 0.96 | 1.18 |
Capex per Share |
(0.22) | 0.04 | (0.23) | (1.00) | (0.60) | (0.65) | (0.56) | (0.32) | (0.62) | (0.26) |
Free Cash Flow per Share |
0.13 | 0.38 | 0.30 | (0.29) | 0.40 | 0.24 | 0.29 | 0.21 | 0.34 | 0.92 |
Cash per Share |
0.15 | 0.15 | 0.20 | 0.13 | 0.48 | 0.01 | 0.01 | 0.01 | 0.02 | 0.15 |
Shareholders Equity per Share |
2.24 | 1.36 | 0.95 | 1.13 | 2.03 | 2.35 | 2.32 | 2.49 | 2.70 | 2.78 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.24 | 1.36 | 0.95 | 1.13 | 2.03 | 2.35 | 2.32 | 2.49 | 2.70 | 2.78 |
Free Cash Flow |
2.94 | 8.64 | 6.41 | (5.77) | 8.12 | 4.98 | 6.04 | 4.49 | 7.22 | 19.03 |
Working Capital |
4.33 | 5.19 | 2.75 | (2.54) | 6.77 | 9.17 | 10.31 | 14.91 | 14.50 | 16.15 |
Capital Expenditures |
(4.97) | 0.92 | (4.98) | (19.64) | (12.16) | (13.34) | (11.48) | (6.73) | (13.24) | (5.38) |
Net Current Asset Value |
(24.89) | (20.26) | (26.09) | (37.58) | (26.47) | (27.25) | (26.61) | (19.99) | (13.92) | (6.90) |
EV/EBIT |
88.79 | 0.00 | 248.45 | 57.88 | 46.08 | 135.59 | 128.65 | 59.51 | 29.49 | 16.94 |
Capex to Sales |
0.07 | (0.01) | 0.07 | 0.24 | 0.12 | 0.13 | 0.10 | 0.05 | 0.10 | 0.04 |
Price to Operating Income |
56.89 | 0.00 | 177.54 | 47.75 | 42.78 | 123.92 | 108.61 | 52.41 | 26.08 | 15.55 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.40 | 7.69 | 7.85 | 3.07 | 3.27 | 3.27 | 3.06 | 2.92 | 3.12 | 3.98 |
Cash ROIC |
3.31% | 13.74% | 10.95% | (9.10%) | 9.10% | 6.10% | 7.43% | 5.50% | 8.81% | 23.75% |
Accounts Receivable Turnover |
5.83 | 6.22 | 6.43 | 7.48 | 7.26 | 6.80 | 6.81 | 6.85 | 6.58 | 6.51 |
Accounts Payable Turnover |
4.33 | 5.12 | 4.37 | 4.55 | 5.24 | 5.99 | 6.09 | 7.67 | 7.22 | 6.11 |
Inventory Turnover |
12.62 | 14.10 | 13.72 | 13.29 | 13.09 | 12.64 | 11.27 | 11.17 | 9.97 | 10.59 |
Average Days of Payables |
75.32 | 72.64 | 93.88 | 84.89 | 64.05 | 65.45 | 61.69 | 46.64 | 55.77 | 62.55 |
Days of Inventory on Hand |
30.69 | 23.23 | 29.84 | 30.91 | 28.36 | 32.79 | 35.65 | 37.28 | 36.97 | 31.16 |
Average Receivables |
12.10 | 11.43 | 10.44 | 10.85 | 13.41 | 15.06 | 16.14 | 18.35 | 20.49 | 22.03 |
Average Payables |
5.95 | 5.42 | 6.30 | 7.53 | 7.37 | 7.32 | 8.10 | 8.18 | 8.93 | 10.33 |
Average Inventory |
2.04 | 1.97 | 2.01 | 2.58 | 2.95 | 3.47 | 4.38 | 5.61 | 6.47 | 5.96 |
Average Assets |
95.85 | 82.61 | 66.48 | 71.65 | 88.11 | 97.29 | 98.49 | 101.15 | 103.26 | 102.09 |
Average Common Equity |
50.50 | 40.82 | 25.70 | 21.39 | 31.54 | 44.51 | 48.14 | 50.15 | 54.92 | 57.43 |
Columns are period end dates